A bioequivalence study is usually conducted with the same-day drug administration. However, hospitalization is occasionally separated for logistical, operational, or other reasons. Recently, there was a case of separate hospitalization because of difficulties in subject recruitment. This article suggests a better way of bioequivalence data analysis for the case of separate hospitalization. The key features are (1) considering the hospitalization date as a random effect than a fixed effect and 2) using “PROC MIXED” instead of “PROC GLM” to include incomplete subject data.
|Number of pages||8|
|Journal||Translational and Clinical Pharmacology|
|Publication status||Published - 2017|
Bibliographical notePublisher Copyright:
© 2017 Translational and Clinical Pharmacology.
All Science Journal Classification (ASJC) codes
- Pharmacology (medical)